American Health Intel
The Ledger · Monday, July 27, 2026

The Ledger

Rules. Money. Medicine. Decoded daily.
Reading as

7.3 percent: that is how far Universal Health Services’ stock fell within hours of beating Wall Street’s second quarter revenue estimate, after the hospital and behavioral health operator cut its full year profit guidance. Universal Health Services (UHS) reported second quarter 2026 net revenue of 4.638 billion dollars, up 8.3 percent year over year and above analyst estimates, with net income attributable to UHS of 358.4 million dollars and diluted earnings per share of 5.98 dollars, up from 5.43 dollars a year earlier. The company narrowed its full year 2026 guidance to adjusted diluted earnings per share of 22.28 to 23.65 dollars, down from a prior range of 22.64 to 24.52 dollars, and to adjusted EBITDA net of noncontrolling interests of 2.610 to 2.717 billion dollars, down from 2.641 to 2.789 billion dollars, citing a roughly 72 million dollar net pretax hit tied to Florida Medicaid program timing and liability reserve adjustments; free cash flow margin contracted to 4.7 percent from 6.6 percent a year earlier. Shares fell as much as 7.3 percent to 147.55 dollars following the release. Confidence: High on the reported and guidance figures, since they come directly from the company’s own earnings release; Medium on the exact stock move percentage, since it is drawn from real time market reporting rather than a verified closing print. Sources: Universal Health Services, Inc. Announces Financial Results for the Three and Six-Month Periods Ended June 30, 2026, and Revises 2026 Full Year Operating Results Forecast, PR Newswire, Universal Health Services (NYSE:UHS) Surprises With Q2 CY2026 Sales But Stock Drops, StockStory via Financial Content.

1.272 billion dollars: that is what a private equity firm paid to take a medical device maker off the New York Stock Exchange today. American Industrial Partners completed its acquisition of Avanos Medical, Inc. on July 27, 2026, paying 25.00 dollars a share in cash for a transaction valued at approximately 1.272 billion dollars; Avanos, based in Alpharetta, Georgia, makes devices spanning pain management, respiratory care and enteral feeding, and its common stock ceased trading on the New York Stock Exchange with the deal’s close. Avanos stockholders approved the deal July 22, 2026 with about 99.75 percent of votes cast in favor, representing roughly 74.96 percent of shares outstanding, capping a path that began with regulatory clearance July 2. Confidence: High, since the deal terms and closing come directly from the companies’ own joint release. Source: American Industrial Partners Completes Acquisition of Avanos Medical, Inc., PR Newswire.

4 days: that is all the runway left for Miami’s academic health system and the nation’s largest insurer before hundreds of thousands of patients go out of network. As of July 27, 2026, UHealth, the University of Miami’s health system, and UnitedHealthcare remain without a new contract, with the July 31 deadline this issue has tracked since July 22 unchanged; UnitedHealthcare says it continues to exchange proposals with UHealth, but neither side has announced a deal, and UHealth’s own negotiation page tells patients to keep scheduled appointments and book new ones through July 31 as normal. Miss the deadline, and UHealth’s hospitals, clinics and physicians, anchored by the Bascom Palmer Eye Institute, go out of network August 1 for UnitedHealthcare’s commercial, Affordable Care Act exchange and Medicaid plans; a separate carve out keeps UnitedHealthcare’s Medicare Advantage Preferred Care Network members in network through August 31 regardless of the outcome. Confidence: High on the deadline and each side’s public position, since both come from the parties’ own pages; Low on whether a deal is struck in time, since neither side has signaled a breakthrough. Sources: UHealth and UnitedHealthcare Negotiation, University of Miami Health System, Network Negotiations with Miami Health System (UHealth), UnitedHealthcare.

650 million dollars: that is the pro forma enterprise value of a deal taking a chain of longevity and regenerative medicine clinics public through a blank check company. First Choice Healthcare Solutions, Inc. and Westin Acquisition Corp., a Nasdaq listed special purpose acquisition company, announced a definitive business combination agreement July 22, 2026 that values First Choice at approximately 650 million dollars on a pro forma enterprise basis; First Choice operates functional health, longevity and regenerative medicine clinics combining primary care, wellness, regenerative therapies and medical weight loss. The combined company will be renamed Wellgevity 360, Inc. and trade on Nasdaq, with Westin domesticating from the Cayman Islands to Nevada ahead of a close expected in the fourth quarter of 2026, subject to shareholder votes and SEC registration statement effectiveness. Confidence: High on the deal terms, since they come directly from the companies’ own joint release; Medium on the eventual trading debut, since the transaction still requires both shareholder approvals and SEC effectiveness. Source: First Choice Healthcare Solutions, Inc. and Westin Acquisition Corp Announce Definitive Business Combination Agreement to Create a Publicly Traded Healthcare and Wellness Company, GlobeNewswire.

FRONTIER SCAN. 650: that is how many dental practices a Canadian consolidator now supports across North America after making its first ever acquisition inside the United States. Dentalcorp, Canada’s largest dental service organization, announced July 21, 2026 that it acquired Northstar Dental Partners, a 21 practice group headquartered in Boca Raton, Florida with sites across South Florida, the Treasure Coast, Southwest Florida and Central Florida, marking Dentalcorp’s entry into the US market and pushing its supported network past 650 practices; financial terms were not disclosed, and Northstar founder and chief executive officer Jordan Tomalty retains an ownership stake. The deal lands amid a broader wave of US dental service organization consolidation, where scale platforms such as Heartland Dental, Aspen Dental and Pacific Dental Services already support a large share of practicing dentists beneath a fast growing tier of private equity backed mid market roll ups. This scan adds Group Dentistry Now (groupdentistrynow.com), whose near daily deal roundups are the strongest recurring tracker found for this vertical, to our source stack. Confidence: High on the deal’s existence and Northstar’s footprint, since both come from Dentalcorp’s own announcement; Low on the financial terms, since they were not disclosed. Source: Dentalcorp Enters the U.S. With Landmark Acquisition of Florida’s Northstar Dental Partners, Business Wire.

THE DEAL SHEET

TargetAcquirer/InvestorVerticalValueSource
Avanos Medical, Inc.American Industrial PartnersMedical devices, pain management, respiratory and enteral feeding$25.00/share cash, approximately $1.272 billion, closed July 27American Industrial Partners Completes Acquisition of Avanos Medical, Inc., PR Newswire
Northstar Dental PartnersDentalcorpDental service organizationUndisclosedDentalcorp Enters the U.S. With Landmark Acquisition of Florida’s Northstar Dental Partners, Business Wire
First Choice Healthcare Solutions, Inc.Westin Acquisition Corp. (SPAC combination, renamed Wellgevity 360, Inc.)Longevity and regenerative medicine clinicsApproximately $650 million pro forma enterprise value; expected to close Q4 2026First Choice Healthcare Solutions, Inc. and Westin Acquisition Corp Announce Definitive Business Combination Agreement, GlobeNewswire

Universal Health Services reported today. Centene reports around July 28, followed by Boston Scientific and Teladoc Health July 29, Humana also July 29, Cigna July 30, and Privia Health, agilon health, Oscar Health and Clover Health cluster in early August.

Get tomorrow's edition in your inbox.

Free, daily. Three editions, pick your field.

Where these stories are tracked
Get the next issue Free, daily